Picture of WuXi AppTec Co logo

2359 WuXi AppTec Co Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-13.17%
3m+4.31%
6m+13.49%
1yr+71.72%
Volume Change (%)
10d/3m+32.98%
Price vs... (%)
52w High-24.61%
50d MA-7.03%
200d MA+15.59%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)12.77
PEG Ratio (f)0.55
EPS Growth (f)30.22%
Dividend Yield (f)2.48%
Valuation (ttm)IndustryMarket
Price to Book Value2.65
Price to Tang. Book2.77
Price to Free Cashflow18.5
Price to Sales3.96
EV to EBITDA10.56

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital18.07%
Return on Equity16.62%
Operating Margin29.51%

Financial Summary

Year End 31st DecUnit202020212022202320242025E2026ECAGR / Avg
Total RevenueCNYm16,535.4322,902.3939,354.7840,340.8139,241.4342,777.7447,893.4624.97%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+45.48+53.64+79.68+17.54-9.81+42.96+11.1n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of WuXi AppTec Co EPS forecast chart

Profile Summary

WuXi AppTec Co Ltd is a China-based company principally engaged in the business of new drug research and development and manufacturing services. The Company conducts its business through six segments. The WuXi Chemistry Segment is primarily engaged in providing new drug research, development and manufacturing services. The WuXi Testing Segment is primarily engaged in providing pharmaceuticals, medical devices, and in vitro diagnostic reagents services. The WuXi Biology Segment is primarily engaged in providing drug discovery and research services. The WuXi ATU Segment is primarily engaged in providing customers with integrated medical product process development, manufacturing and testing services. The WuXi DDSU Segment is primarily engaged in providing customers with integrated new drug research and development services. The Other Segment is primarily engaged in administrative services, sales of raw materials and sales of waste materials.

Directors

Last Annual
December 31st, 2024
Last Interim
December 31st, 2024
Incorporated
December 1st, 2000
Public Since
May 8th, 2018
No. of Shareholders
300,597
No. of Employees
39,414
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
hk flag iconStock Exchange of Hong Kong Limited
Shares in Issue
2,887,992,582
Blurred out image of a map
Address
228 Fute Zhong Road, SHANGHAI, 200131
Web
https://www.wuxiapptec.com/
Phone
+86 2150461000
Auditors
Deloitte Touche Tohmatsu CPA Ltd.

2359 Share Price Performance

Upcoming Events for 2359

Similar to 2359

Picture of Abbisko Cayman logo

Abbisko Cayman

hk flag iconStock Exchange of Hong Kong Limited

Picture of Akeso logo

Akeso

hk flag iconStock Exchange of Hong Kong Limited

Picture of Alphamab Oncology logo

Alphamab Oncology

hk flag iconStock Exchange of Hong Kong Limited

Picture of Antengene logo

Antengene

hk flag iconStock Exchange of Hong Kong Limited

Picture of Ascentage Pharma International logo

Ascentage Pharma International

hk flag iconStock Exchange of Hong Kong Limited

FAQ